Sartorius Stedim Biotech S.A. Stock
Sartorius Stedim Biotech S.A. gained 0.480% compared to yesterday.
So far the community has only identified positive things for Sartorius Stedim Biotech S.A. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Sartorius Stedim Biotech S.A. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sartorius Stedim Biotech S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sartorius Stedim Biotech S.A. | 0.480% | -1.759% | -18.041% | -19.352% | -14.018% | -43.678% | 72.538% |
| bioMerieux S.A. | 0.000% | -2.637% | 4.672% | 2.235% | -1.238% | 2.911% | 41.118% |
| EssilorLuxottica SA | 2.890% | -1.363% | -2.426% | 7.956% | 9.464% | 42.566% | 85.854% |
| Dentsply Sirona Inc. | 0.840% | -8.380% | -12.005% | -29.310% | -18.459% | -53.042% | -46.185% |
Comments
Sartorius Stedim Biotech S.A. (OTCMKTS: SDMHF) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Show more
Ratings data for SDMHF provided by MarketBeat
News
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL